"Learning Party History and Celebrating One Hundred Years" Essay Notice
Release time:
2021-04-01
1. essay-writing theme:
"Learning Party History and Celebrating Centennial" to commemorate the founding of the Communist Party of China 100 anniversary of China.
2. essay writing time:
from today to 2021 6 10 .
3. essay requirements:
1, essay content: around the themes of "100-year-old party, 100-year-old celebration", "looking back on the party history, keeping in mind the mission", etc., learn the party history, praise the party's kindness, talk freely about the cognition and feelings of the revolutionary tradition, enhance the sense of mission and responsibility, and keep in mind the mission to shoulder bravely; Express personal experience and feelings, eulogn the great achievements of the party, praise today's happy and beautiful life; record the touching deeds of the Communist Party members around them serving the people wholeheartedly in their ordinary posts, and express the feelings of the pioneers of the times; tell me about my experience of looking back on the party history, reading red classic books, watching red movies and television, and visiting the red base. It is required that the theme is clear, the point of view is correct, the content is rich, the mission consciousness is strengthened, and the responsibility is reflected.
2, essay writing style: narrative, argumentative, prose, poetry, etc. The length should be from 1000 to 1500 .
3, essay submission: submitted in electronic version (word document form) or in writing, and marked "essay submission" in the file name; The author's name, contact number and subordinate unit shall be attached to the essay document. The paper version of the manuscript is submitted to the office of 311 in Jianfeng Building, and the electronic version is sent to Xu Xufen of the Party and Mass Department of the Group Company through OA system.
4. Selection Recognition:
Essays The Party Committee of the Group Company organizes professionals to select the submitted essays. There are first prize 5 , second prize 10 , third prize 15 , and several outstanding prizes. Award certificates and awards will be issued, and the works will be selected for publication in the Peak Newspaper. Contributions and awards will be one of the contents of the year-end party appraisal. Party members, cadres and workers are welcome to contribute and participate actively. 55
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31